Study Evaluating Nasal Symptoms Induced by a Nasal Allergen Challenge (NAC) To House Dust Mite Allergen
NCT01936818 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21
Last updated 2015-10-22
Summary
A Multi-Center Study Evaluating the Nasal Allergic Symptomatology Induced by a Nasal Allergen Challenge (NAC) in a Dust Mite Population
Conditions
- Allergic Rhinitis
Sponsors & Collaborators
-
ORA, Inc.
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-08-31
- Primary Completion
- 2015-01-31
- Completion
- 2015-01-31
Countries
- United States
Study Locations
More Related Trials
-
Effect of a Nasal Bolus Allergen Challenge on Inflammatory Markers
NCT00483353 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Norketotifen in Adults With Allergic Rhinitis
NCT03887026 ·Status: COMPLETED ·Phase: PHASE2
-
Sensitivity and Specificity of Nasal Provocation Test in Allergic Rhinitis to House Dust Mites
NCT01485523 ·Status: COMPLETED
-
Evaluation of Nasal Mucosal Permeability in Controls and House Dust Mite Allergic Rhinitis Patients
NCT02461797 ·Status: COMPLETED ·Phase: NA
-
A Study Comparing Montelukast With Placebo in Children With Seasonal Allergic Rhinitis (0476-219)(COMPLETED)
NCT00968149 ·Status: COMPLETED ·Phase: PHASE3
-
Nasal Epithelium Gene Expression Profiling in Child Respiratory Allergic Disease
NCT00569361 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)
NCT01700192 ·Status: COMPLETED ·Phase: PHASE3
-
MK-8237 (SCH900237) Biomarker Study in Participants With Allergic Rhinitis or Rhinoconjunctivitis (MK-8237-009)
NCT01852825 ·Status: COMPLETED ·Phase: PHASE1
-
Nasal Provocation Testing in Occupational Rhinitis
NCT01436851 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of House Dust Mite Allergen Extract in the Treatment of Allergic Rhinoconjunctivitis
NCT00263549 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MEMP1972A in Patients With Allergic Rhinitis
NCT01160861 ·Status: COMPLETED ·Phase: PHASE1
-
A Single-Center Evaluation of the Pattern of Allergic Signs and Symptoms During 4 Weeks in Ragweed Season
NCT00982163 ·Status: COMPLETED
-
MK0524 Seasonal Allergic Rhinitis Study (0524-005)(COMPLETED)
NCT00533208 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Study Evaluating the Signs and Symptoms of Seasonal Allergic Rhinoconjunctivitis Following Exposure in the Allergen BioCube
NCT00985075 ·Status: COMPLETED
-
Safety of ToleroMune House Dust Mite (HDM) to Treat House Dust Mite Allergy in HDM Allergic Subjects With Rhinoconjunctivitis
NCT01008332 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of House Dust Mite Allergoid in the Treatment of Bronchial Asthma
NCT00263640 ·Status: COMPLETED ·Phase: PHASE3
-
Nasal Irritation Study: Individual Factors in Nasal Irritant Sensitivity
NCT00041821 ·Status: COMPLETED ·Phase: NA
-
Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis
NCT01484119 ·Status: COMPLETED ·Phase: PHASE3
-
Mediators in Nasal Hyperreactivity in Allergic Rhinitis and Chronic Rhinosinusitis
NCT04286542 ·Status: UNKNOWN ·Phase: NA
-
Validation of a Combined Symptom and Medication Score in Patients Suffering From Allergic Rhinoconjunctivitis
NCT04071249 ·Status: COMPLETED
-
Effects of Intranasal Corticosteroid and Montelukast On Nasal Allergen Challenges*
NCT01240889 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study With Allergen Extracts of House Dust Mites for Specific Sublingual Immunotherapy
NCT01014325 ·Status: UNKNOWN ·Phase: PHASE3
-
The Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis (0476-265)
NCT00092118 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of AM-301 on Allergic Symptoms of Perennial Allergic Rhinitis Sufferers
NCT05122143 ·Status: COMPLETED ·Phase: NA
-
A Single and Multiple Dose Study to Explore the Safety of JNJ-38224342 in Healthy Patients and Patients With Seasonal Allergies
NCT01054352 ·Status: COMPLETED ·Phase: PHASE1